Heparin monitoring in sheep by activated partial thromboplastin time

被引:7
|
作者
Park, SG
Kim, SC
Choi, MJ
Lee, HS
Min, BG
Cheong, J
Lee, K [1 ]
机构
[1] Cheju Natl Univ, Dept Vet Med, Coll Agr, Jeju, South Korea
[2] Cheju Natl Univ, Inst Artificial Heart, Coll Agr, Jeju, South Korea
[3] Hanmaeum Gen Hosp, Dept Thorac & Cardiovasc Surg, Jeju, South Korea
[4] Cheju Natl Univ, Dept Med, Sch Med, Jeju, South Korea
[5] Seoul Natl Univ, Interdisciplinary Program Biomed Engn Major, Coll Engn, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Inst Med & Biol Engn,Med Res Ctr, Seoul, South Korea
关键词
heparin; activated partial thromboplastin time; platelet count; sheep;
D O I
10.1046/j.1525-1594.2003.07090.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Heparin anticoagulation is utilized during and after vascular surgery in animals to reduce the risk of acute or chronic thromboembolic problems. In this study, we examined variation of activated partial thromboplastin time APTT) after the intravenous bolus IV bolus) and subcutaneous SC) heparin injection in order to monitor heparin therapy in sheep. Nine healthy sheep were assigned to 3 groups A, B, and C) according to their body weights: less than 40 kg, 40 to 80 kg, and more than 80 kg, respectively. All animals were treated with heparin 300 IU/kg body weight) through two routes, and the APTT, fibrinogen, and platelet count were measured before and every hour after treatment. This showed that the APTT was increased significantly between 1 to 4 hours after IV bolus injection and between 2 to 6 hours after SC injection P < 0.05). The APTT was returned to baseline values 6 and 10 hours after the respective treatments. The APTT in Group C was consistently higher than in Group A and B after heparin treatment by the two routes. The APTT ratio entered the subtherapeutic range 5 and 8 hours after IV bolus and SC injection, respectively. The APTT ratio was maintained in the therapeutic range for about 1 and 4 hours after IV bolus and SC injection, respectively. The highest APTT ratio in Group C after SC injection of heparin was significantly higher than that in Groups A and B P < 0.05). The mean platelet counts in Groups A, B, and C before the injection were 3,197 +/- 365.6, 2,886 +/- 78.2, and 1,861 +/- 298.0 10(2) /muL, respectively. The mean platelet count gradually decreased without significant variation after IV bolus and SC injection. These results produced elementary data for monitoring in sheep using APTT, and suggested that heparin should be administrated by the SC route at 4-hour intervals in order to remain in the therapeutic range, after an initial IV bolus dose.
引用
收藏
页码:576 / 580
页数:5
相关论文
共 50 条
  • [21] The Determinants of Activated Partial Thromboplastin Time, Relation of Activated Partial Thromboplastin Time to Clinical Outcomes, and Optimal Dosing Regimens for Heparin Treated Patients with Acute Coronary Syndromes: A Review of GUSTO-IIb
    Michael S. Lee
    Andreas U. Wali
    Venu Menon
    Scott D. Berkowitz
    Trevor D. Thompson
    Robert M. Califf
    Eric J. Topol
    Christopher B. Granger
    Judith S. Hochman
    Journal of Thrombosis and Thrombolysis, 2002, 14 : 91 - 101
  • [22] Comparing a piezoelectric quartz crystal with an optical coagulometer in monitoring high-dose heparin therapy by determining whole blood activated partial thromboplastin time and activated clotting time
    Lin, TM
    Cheng, TJ
    Wu, TH
    Chang, HC
    SENSORS AND ACTUATORS B-CHEMICAL, 2005, 109 (02) : 270 - 277
  • [23] ENZYMATIC ELIMINATION OF HEPARIN FROM PLASMA FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME AND PROTHROMBIN TIME TESTING
    VANDENBESSELAAR, AMHP
    MEEUWISSEBRAUN, J
    BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (04) : 635 - 638
  • [24] EFFECT OF CLOT-DETECTION METHODS AND REAGENTS ON ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) - IMPLICATIONS IN HEPARIN MONITORING BY APTT
    DANGELO, A
    SEVESO, MP
    DANGELO, SV
    GILARDONI, F
    DETTORI, AG
    BONINI, P
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (03) : 297 - 306
  • [25] Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study
    Samuel, S.
    Allison, T. A.
    Sharaf, S.
    Yau, G.
    Ranjbar, G.
    Mckaig, N.
    Nguyen, A.
    Escobar, M.
    Choi, H. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (05) : 499 - 502
  • [26] Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation
    Thompson, Molly H.
    Wilson, Sylvia H.
    Toussaint, Brittany L.
    Jordan, Cameron L.
    Hayes, Genevieve L.
    McKinzie, Brian P.
    Wolf, Bethany J.
    Field, Larry C.
    JOURNAL OF CLINICAL ANESTHESIA, 2016, 33 : 346 - 350
  • [27] Correlation between activated clotting time and activated partial thromboplastin times
    Smythe, MA
    Koerber, JM
    Nowak, SN
    Mattson, JC
    Begle, RL
    Westley, SJ
    Balasubramaniam, M
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (01) : 7 - 11
  • [28] Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time
    Cuker, A.
    Ptashkin, B.
    Konkle, B. A.
    Pipe, S. W.
    Whinna, H. C.
    Zheng, X. L.
    Cines, D. B.
    Pollak, E. S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (01) : 80 - 86
  • [29] The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy
    Lapic, Ivana
    Vrancic, Ana Loncar
    Herak, Desiree Coen
    Rogic, Dunja
    BIOCHEMIA MEDICA, 2021, 31 (02) : 021003